Wize Pharma, Inc. Uncategorized Contracts & Agreements
50 Contracts & Agreements
- Director Appointment Letter between the Company and Ryan Costello dated September 25, 2023 (Filed With SEC on September 28, 2023)
- Chief Financial Officer Offer Letter and Exhibit A (Filed With SEC on July 14, 2023)
- Letter Deed of Departure by and between Mawson Infrastructure Group Pty Ltd and James Manning, dated May 22, 2023 (Filed With SEC on May 25, 2023)
- Description of Securities (Filed With SEC on March 23, 2023)
- Director Appointment Letter between the Company and Rahul Mewawalla dated January 31, 2023 (Filed With SEC on January 31, 2023)
- At The Market Offering Agreement between Mawson Infrastructure Group Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on May 27, 2022)
- Description of Securities (Filed With SEC on March 21, 2022)
- Resignation letter of Or Eisenberg (Filed With SEC on August 20, 2021)
- Amendment to Convertible Loans Agreements dated November 29, 2019 (Filed With SEC on July 27, 2021)
- Warrants issued to W Capital Advisors Pty Limited (Filed With SEC on June 9, 2021)
- Description of Securities (Filed With SEC on March 1, 2021)
- Form of Contingent Value Rights Agreement (Filed With SEC on January 19, 2021)
- Deed of Amendment, dated January 18, 2021, of the Bid Implementation Agreement between Wize Pharma, Inc. and Cosmos Capital Limited, dated December 30, 2020 (Filed With SEC on January 19, 2021)
- Form of Contingent Value Rights Agreement (Filed With SEC on January 5, 2021)
- Bid Implementation Agreement, between Wize Pharma, Inc. and Cosmos Capital Limited, dated December 30, 2020 (Filed With SEC on January 5, 2021)
- Description of Securities (Filed With SEC on March 30, 2020)
- Chairman Agreement between the Company and Mark Sieczkarek dated as of April 23, 2019 (Filed With SEC on April 29, 2019)
- Letter Amendment to Convertible Loans, dated as of December 21, 2017, by and between Wize Pharma, Inc., Wize Pharma Ltd., Ridge Valley Corporation, Rimon Gold Assets Ltd. and... (Filed With SEC on December 27, 2017)
- Agreement dated September 25, 2017 between Resdevco Ltd. and Wize Pharma Ltd (Filed With SEC on November 21, 2017)
- Letter dated September 6, 2017 from Resdevco Ltd (Filed With SEC on November 21, 2017)
- Finders Agreement dated June 19, 2017 between Wize Pharma Ltd. and Harbin Israel (Trading) Ltd (Filed With SEC on July 27, 2017)
- Private Placement Agreement dated June 23, 2017 between Wize Pharma Ltd. and Peretz Yosef Eliahu (Filed With SEC on July 27, 2017)
- Private Placement Agreement dated June 23, 2017 between Wize Pharma Ltd. and Yaacov Zrachia (Filed With SEC on July 27, 2017)
- Private Placement Agreement dated June 23, 2017 between Wize Pharma Ltd. and Simcha Sadan (Filed With SEC on July 27, 2017)
- Addendum to Private Placement Agreement dated June 15, 2017 between Wize Pharma Ltd. and Jonathan Brian Rubini (Filed With SEC on July 27, 2017)
- Private Placement Agreement dated May 25,2017 between Wize Pharma Ltd. and Jonathan Brian Rubini (Filed With SEC on July 27, 2017)
- Assumption Agreement dated August 30, 2016 between Resdevco Ltd. and OcuWize Ltd (Filed With SEC on July 27, 2017)
- Correction to Licensing Agreement dated June 16, 2017 between Resdevco Ltd. and Wize Pharma Ltd (Filed With SEC on July 27, 2017)
- Second Addition to Amendment to Licensing Agreement dated March 30, 2017 between Resdevco Ltd. and Wize Pharma Ltd (Filed With SEC on July 27, 2017)
- Addition to Amendment to Licensing Agreement dated January 6, 2017 between Resdevco Ltd. and Wize Pharma Ltd (Filed With SEC on July 27, 2017)
- Amendment No. 2 to Licensing Agreement Ukraine Market dated May 31, 2016 between Resdevco Ltd. and Wize Pharma Ltd (Filed With SEC on July 27, 2017)
- Amendment No. 1 to Licensing Agreement Israeli Market dated May 31, 2016 between Resdevco Ltd. and Wize Pharma Ltd (Filed With SEC on July 27, 2017)
- Amendment No. 2 to Licensing Agreement dated March 20, 2016 between Resdevco Ltd. and Wize Pharma Ltd (Filed With SEC on July 27, 2017)
- Amendment to Licensing Agreement dated November 22, 2015 between Resdevco Ltd. and Wize Pharma Ltd (Filed With SEC on July 27, 2017)
- SHAREPURCHASE AGREEMENT (Filed With SEC on June 19, 2015)
- Made as of the 1 day of July, 2013 (Filed With SEC on March 27, 2014)
- OPHTHALIX INC. (Filed With SEC on July 2, 2013)
- Made as of the 1 day ofJuly, 2013 (Filed With SEC on July 2, 2013)
- EXHIBIT B TERMS OF THE OPTION (Filed With SEC on July 2, 2013)
- Made as of the 28 day of April, 2013 (Filed With SEC on July 2, 2013)
